Karin Amundson

机构：Cidara Therapeutics (United States)

发表论文 49 篇 · 总被引 1115 次 · h-index 8

代表论文

• Drug–Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice (2025 · Nature Microbiology · 被引 15)
• Abstract LB131: CBO421, a novel drug Fc-conjugate, inhibits the enzymatic activity of CD73 and triggers CD73 internalization (2024 · Cancer Research · 被引 3)
• CD388: A universally protective Drug-Fc Conjugate that targets influenza virus neuraminidase (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Abstract 2668: CBO421: A novel drug Fc-conjugate to prevent tumor immune evasion via the CD73/adenosine pathway (2024 · Cancer Research · 被引 1)
• 2062. In Vivo Efficacy of CD388, a Novel Drug Fc-Conjugate (DFC), Against Seasonal Subtypes of Influenza in Prophylaxis in Immune Competent Mice, and in a Severe Immunodeficient (SCID) Mouse Model (2023 · Open Forum Infectious Diseases · 被引 1)
• 1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer (2023 · Regular and Young Investigator Award Abstracts · 被引 1)